If close to zero understanding counts, my evolving viewpoint is that this can remain as a public company in good stewardship. It might be Joe's company (and David's), but Kerri Wagner knows as much as anyone about the attributes of the sweat patch. She worked on the S.D. 24/7 sobriety, and her success in the corrections industry is well documented. I don't believe that Kerri and Shana will have a desire to uplist or start filing. Why waste money? Why waste time?
I was impressed with a number of things from their shareholder letter. Operating margins grew from 20-25%. With a small uptick in SGA, they were still able to grow revenues significantly. Six employees. We are looking at $1 million per employee. They outsource where they needed to, they updated the site. Some of the regulatory issues will have to be addressed, as well as some potential gross margin pressure (or not). If you have been following the story, there was no follow up news to a forensic toxicologist, we had no news on expanding the profile (like fentanyl as an obvious choice), but I guess the patch is what it is. From an investor standpoint, we have no R&D expenses. So while I'm jumping around a bit, this is still a profitable machine; on top of that, we pay almost no taxes and our cash position is burgeoning. We have won every court case. So if you read negative this and that online over the past 10-15 years about contamination - too sensitive a device, that's fine, because we are still growing and winning. And false negatives and BS happens with hair tests and Urine and oral too probably.
My hope was to meet with Joe when he comes to New York. But I don't believe in wasting his time, no matter how much stock this board owns.
20 percent? That's if our 60 cent buyer from a year ago started here and is continuing to suck in as much $1 stock as possible before taking it up.
Deet does amazing work.
He has laid out a case that if :
(1) each drug court ordered a box of patches
or
(2) if each county ordered a box of patches
or
(3) there were 100,000 users a year put on the patch from the 24/7 program
My point being that he has looked at a few of MANY types of revenue streams
And he correctly brings up alcopro lab and arcpoint as potential buyers
And Redlepper correctly says they need to address other markets. Mom's and Dads. Teenagers
Boats need patching. Forget putting it on shoulderes. This stuff is better than Flex Seal
The mighty roars of warrior tribes are arising Redlepper.
I grew up in the 70's when heroin addiction was terrible. Someonetried to break in to my apartment for drug money. What we see now is terrible. RECORD NUMBERS OF DRUG DEATHS.
Personally, my town is a tragedy. A relatively well to do (not me, I just own PCHM) town in northern Long Island, near the "gold coast". These families have money. Good kids.
And all it takes is one snort, one painkiller, or god forbid, one needle. FOUR KIDS FROM ONE GROUP OF FRIENDS OVER A FIVE YEAR PERIOD ARE GONE.
I'm not saying drug testing would have saved lives. But it always is a part of the solution where money needs to get thrown at. Obama's transportation bill provided that with state grant money. Trump has made his declarations.
Everyone here should read about the opiod epidemic. In all this tragedy it is as the company says, an opportunity.
I don't profess to know anything. I thought it would be best to ride this out because of growing revenue streams, especially the expansion of 24/7 programs. If all 50 states were on board, this would (in ten? years), my short term buyout numbers would turn in to ten baggers. I know nothing.
Of course we need to hope for ONE MORE good shareholder letter. I don't want to hear about margins. I don't want sales growth to slip under double digits, when I see a long term growth rate of 15%-20% for a decade which is dart throwing AND LOW.
Last thought.
Can we find this company a financial buyer please.
Clearly it is not a proper fit for someone in the industry or we would have heard something. The company did THREE AUDITS. It's a pink sheet quiet company. They've tried to sell, but they are not looking under the right rocks.
Can we cash this thing out at 4 this year and move on with our lives.
Or are we going to have to stick around for double digits?
All in my opinion.
Signed,
One shot of Makers Mark
News 
Market Data 
Discover 
